Skip to content Skip to footer

Africa cannabis market could be worth over $US 7.1 billion annually by 2023

Africa cannabis market could be worth over $US 7.1 billion annually by 2023
Share this story

The first detailed report on the legal cannabis industry in Africa finds that the continent could reap significant rewards through the legalisation of cannabis. The report includes detailed market value forecasts, regulatory timeline analysis, consumption data and healthcare analyses for 9 key markets. A complex and challenging region, the African market is newly emerging, and despite a conservative regulatory approach to cannabis, the industry shows signs of promise.

Cultivating an Africa cannabis industry  

Although widely grown across the continent (indeed Africa is estimated to produce at least 38,000 tonnes of cannabis per year) cannabis is illegal in most African countries. High unemployment rates and a global decline in demand for tobacco crops has hit these economies hard. However, the region has a wealth of experience in cannabis cultivation; despite its illegality, many agricultural workers have turned to cannabis farming as the only way to earn enough money to provide for the basic needs of their families.

International demand offers a strong opportunity to unlock the potential value of Africa cannabis, which could be worth up to $7.1 billion annually by 2023 – the bulk of which will come from the production sector.

With affordable land, low-cost labour and an experienced agricultural workforce, Africa offers enormous opportunity to local start-ups and foreign companies looking to expand. However, an inadequate healthcare system means that even if medicinal cannabis were to be legalised across the continent, access to products would be limited.

legal african cannabis

Uncertainty over access to African cannabis 

Companies and entrepreneurs seeking to invest in the cannabis industry in Africa face other structural hurdles. The region has an extremely high rate of HIV/AIDS (more than one-fifth of all adults are estimated to suffer from the immune deficiency condition). Although there is evidence to suggest medical cannabis can support in the treatment of the virus, cannabis may not present itself as a priority treatment.

In addition, a heavy reliance on donor-supported healthcare funding will likely limit patient access to cannabis in the short-term. For instance, UNICEF reports that Malawi’s health sector is 80% funded by foreign donors, which may choose to prioritise vaccinations and other preventative treatments before shifting their attention to medical cannabis supplies.

Should legislation change, NGOs, charities and other donors who provide a significant proportion of the region’s healthcare supplies will be an essential partner in providing access to legal medicinal cannabis products due to the inaccessibility of healthcare services.

High cannabis consumption rates

Supply will remain an issue in the short-term but demand in the region is sky-rocketing. Annual prevalence rates of cannabis use in Africa (13.2%) cement the region as having one of the highest consumption rates around the world. In fact, Africa is home to five of the world’s top 30 countries for cannabis prevalence among adult populations with Nigeria (no.3), Zambia (no.10), Madagascar (no.14), Egypt (no.25) and Sierra Leone (no.30) all making the leaderboard.

With over 76 million black market cannabis users, Africa has a huge potential consumer base, but prices are expected to remain low throughout the region.

African cannabis

Prioritising local needs

Cannabis remains an attractive proposition for international companies seeking to expand their footprint in a region where land and labour is low-cost. Because of the poor economic

conditions faced by many African countries, any legalisation of cannabis in the region will have a duty to safeguard local interests. In this respect, Zimbabwe could become a regional blueprint as licence applications can only come from those who can prove citizenship or residency.

To learn more about the newly emerging African cannabis industry, and examine the opportunities and challenges presented by the conservative legislative climate and complex healthcare systems, download The African Cannabis Report™, released today.

Download Now

Or read the full press release here.

Recent posts
June 2, 2022
Austria Sees Record Imports of Medical Cannabis in 2021
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022

Catch up on our newest articles that you might have missed

joss-woodhead-3wFRlwS91yk-unsplash
June 2, 2022
Austria Sees Record Imports of Medical Cannabis in 2021
Austria sees record imports of medical cannabis in 2021 while a case at the Supreme Court challenges prohibition. Austria is...
Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...